PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
December 14, 2023European Heart JournalOpen Access

Tricuspid valve disease and cardiac implantable electronic devices

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Cardiac implantable electronic device-related tricuspid regurgitation is increasingly recognized, while interventional, surgical, and lead extraction management options continuously evolve.

Design

Multidisciplinary review article

Key result

Interventional treatment options for tricuspid regurgitation associated with cardiac implantable electronic devices are evolving and improving patient management.

Authors

MAMartin AndreasHBHaran BurriFPFabien Praz

Discussion

Loading...

Member takes

Overview

Alerts clinicians to emerging options for CIED-related TR; leaves open optimal strategies pending prospective trials.

Structured PICO

P
Population
Patients suffering from tricuspid regurgitation (TR) associated with or related to cardiac implantable electronic device (CIED) lead(s) or leadless pacemakers

This multidisciplinary review provides an overview of disease mechanisms, diagnostics, and treatment algorithms for patients with CIED-related tricuspid regurgitation.

Cite This Study

Andreas et al. (2023) studied this question. Interventional treatment options for tricuspid regurgitation associated with cardiac implantable electronic devices are evolving and improving patient management.

synapsesocial.com/papers/6962d053f86a112dd98ba671https://doi.org/10.1093/eurheartj/ehad783
View Full Paper
Ask AI
Bookmark
Share